ROLE OF MITOCHONDRIAL DISFUNCTION IN THE DEVELOPMENT OF ALZHEIMER’S DISEASE
V.V. Ganzha, E.A. Lukyanetz
- Bogomoletz Institute of physiology NAS of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz67.01.057
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative
disease characterized by memory loss and multiple cognitive
impairments. Several decades of intensive research have shown
that multicellular changes are involved in AD’s development
and progression, including mitochondrial damage, synaptic
dysfunction, formation and accumulation of beta-amyloid
(Aβ), formation and accumulation of hyperphosphorylated
tau protein, and loss of neurons in patients with this disease.
Among them, mitochondrial dysfunction and synaptic damage
are the primary manifestations in the disease process. Recent
studies have also shown that defective mitophagy caused by Aβ
and tau protein are the main indicators in AD’s pathogenesis.
This review includes an overview of recent researches on
the role of mitochondria in AD development. The review
summarizes several aspects of mitochondrial dysfunction,
including abnormal mitochondrial dynamics, changes in
mitochondrial DNA, and calcium dyshomeostasis in AD
pathogenesis
Keywords:
Alzheimer’s disease; β-amyloi; τ-protein; calcium; hippocampal neurons; mitochondria; mitochondrial dysfunction.
References
- Moneim AE. Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease. Current Alzheimer Res. 2015;12(4):335-49.
CrossRef
PubMed PubMedCentral
- Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006;38(5):515-7.
CrossRef
PubMed
- Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev. 2000;33(1):95-130.
CrossRef
- Calkins MJ, Manczak M, Reddy PH. Mitochondriatargeted antioxidant ss31 prevents amyloid beta-induced mitochondrial abnormalities and synaptic degeneration in Alzheimer's disease. Pharmaceuticals (Basel). 2012;5(10):1103-19.
CrossRef
PubMed PubMedCentral
- Cardoso S, Seica RM, Moreira PI. Mitochondria as a target for neuroprotection: implications for Alzheimer's disease. Expert Rev Neurother. 2017;2016/07/08(1):77-91.
CrossRef
PubMed
- Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 2005;2005/10/06(14):2040-1.
CrossRef
PubMed
- Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother. 2010;10(5):729-45.
CrossRef
PubMed
- Shefa U, Jeong NY, Song IO, Chung HJ, Kim D, Jung J, et al. Mitophagy links oxidative stress conditions and neurodegenerative diseases. Neural Regen Res. 2019;14(5):749-56.
CrossRef
PubMed PubMedCentral
- Eckert A, Schmitt K, Götz J. Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-OI toxicity. Alzheimers Res Ther. 2011;3(2):15-.
CrossRef
PubMed PubMedCentral
- Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001;81(2):741-66.
CrossRef
PubMed
- Gong CX, Grundke-Iqbal I, Iqbal K. Targeting tau protein in Alzheimer's disease. Drugs Aging. 2010;27(5):351-65.
CrossRef
PubMed
- Gwon AR, Park JS, Arumugam TV, Kwon YK, Chan SL, Kim SH, et al. Oxidative lipid modification of nicastrin enhances amyloidogenic Oi-secretase activity in Alzheimer's disease. Aging Cell. 2012; 2012/04/09(4):559-68.
CrossRef
PubMed PubMedCentral
- Reiss AB, Arain HA, Stecker MM, Siegart NM, Kasselman LJ. Amyloid toxicity in Alzheimer's disease. Rev Neurosci. 2018;29(6):613-27.
CrossRef
PubMed
- Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging. 2009;30(10):1574-86.
CrossRef
PubMed
- Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Tonk S, et al. Protective effects of indian spice curcumin against amyloid-OI in Alzheimer's disease. J Alzheimers Dis. 2018;61(3):843-66.
CrossRef
PubMed PubMedCentral
- Reddy PH, Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, et al. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondriatargeted antioxidant therapeutics. Biochim Biophys Acta. 2012;1822(5):639-49.
CrossRef
PubMed PubMedCentral
- Hoglinger GU, Lannuzel A, Khondiker ME, Michel PP, Duyckaerts C, et al. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem. 2005;95(4):930-9.
CrossRef
PubMed
- Hou Y, Ghosh P, Wan R, Ouyang X, Cheng H, Mattson MP, et al. Permeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of amyloid beta1-42 on neural progenitor cell proliferation. Neurobiol Aging. 2014;35(5):975-89.
CrossRef
PubMed PubMedCentral
- Jazin EE, Cavelier L, Eriksson I, Oreland L, Gyllensten U. Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc Natl Acad Sci USA. 1996;93(22):12382-7.
CrossRef
PubMed PubMedCentral
- Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, Lvova M, et al. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging. 2010;31(8):1355-63.
CrossRef
PubMed PubMedCentral
- Leuner K, Miller WE, Reichert AS. From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease. Mol Neurobiol. 2012;46(1):186-93.
CrossRef
PubMed
- Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet. 2002;11(2):133-45.
CrossRef
PubMed
- Pagani L, Eckert A. Amyloid-beta interaction with mitochondria. Int J Alzheimers Dis. 2011:925050.
CrossRef
PubMed PubMedCentral
- Chinnery PF, Johnson MA, Wardell TM, Singh-Kler R, Hayes C, Brown DT, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol. 2000;48(2):188-93.
CrossRef
- Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325(6106):733-6.
CrossRef
PubMed
- Kar S, Slowikowski SP, Westaway D, Mount HT. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiat Neurosci. 2004;29(6):427-41.
- Swerdlow RH. Brain aging, Alzheimer's disease, and mitochondria. Biochim Biophys Acta. 2011; 1812(12):1630-9.
CrossRef
PubMed PubMedCentral
- Jayadev S, Leverenz JB, Steinbart E, Stahl J, Klunk W, Yu CE, et al. Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain. 2010;133(Part 4):1143-54.
CrossRef
PubMed PubMedCentral
- Hung CH-L, Ho YS, Chang RC-C. Modulation of mitochondrial calcium as a pharmacological target for Alzheimer's disease. Aging Res Rev. 2010;9(4):447-56.
CrossRef
PubMed
- Sisodia SS, Annaert W, Kim SH, De SB. Gammasecretase: never more enigmatic. Trends Neurosci. 2001;24(Suppl 11):S2-S6.
CrossRef
- Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on AgingAlzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012;8(1):1-13.
CrossRef
PubMed PubMedCentral
- Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184-5.
CrossRef
PubMed
- Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353-6.
CrossRef
PubMed
- Maruszak A, Żekanowski C. Mitochondrial dysfunction and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiat. 2011;35(2):320-30.
CrossRef
PubMed
- Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet. 2002;11(2):133-45.
CrossRef
PubMed
- Mattson MP, Fu W, Waeg G, Uchida K. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. NeuroReport. 1997;8(9-10):2275-81.
CrossRef
PubMed
- Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D, et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One. 2007;2(6):e536-e.
CrossRef
PubMed PubMedCentral
- Götz J, Ittner LM. Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci. 2008;9(7):532-44.
CrossRef
PubMed
- Kostyk PG, Kostyuk EP, Lukyanetz EA. Intracellular calcium signaling - structures and functions. Kyiv: Naukova Dumka; 2010. 176 p.
- Kostyuk PG, Lukyanetz EA. Intracellular calcium signaling - basic mechanisms and possible alterations. Bioelectromagnetics Current Concepts: Springer Netherlands; 2006. p. 87-122.
CrossRef
- Lukyanets IA, Lukyanetz EA. Calcium signalling during hypoxia in fish Carasius gibelio. Fiziol Zh. 2009;55(6).
CrossRef
- Lukyanets IA, Lukyanetz EA. Modulation of calcium signalling by the endoplasmic reticulum in Carassius neurons. Biochem Biophys Res Commun. 2013;433(4):591-4.
CrossRef
PubMed
- Lukyanets IA, Yavorskaya EN, Tokar' SL, Lukyanetz EA. Roles of the mitochondria and endoplasmic reticulum in calcium elevation during osmotic shock in adrenocortical cells. Neurophysiology. 2002;34(2-3):177-9.
CrossRef
- Lukyanetz EA, Shkryl VM, Kravchuk OV, Kostyuk PG. Action of hypoxia on different types of calcium channels in hippocampal neurons. Biochim Biophys Acta - Biomembranes. 2003;1618(1):33-8.
CrossRef
PubMed
- Lukyanetz EA, Shkryl VM, Kravchuk OV, Kostyuk PG. Effect of hypoxia on calcium channels depends on extracellular calcium in CA1 hippocampal neurons. Brain Res. 2003;980(1):128-34.
CrossRef
- Lukyanetz EA, Stanika RI, Koval LM, Kostyuk PG. Intracellular mechanisms of hypoxia-induced calcium increase in rat sensory neurons. Arch Biochem Biophys. 2003;410(2):212-21.
CrossRef
- Lukyanetz IA, Kostyk PG, Lukyanetz EA. The involvement of calcium transport systems of the plasma membrane in calcium exchange in neurons of the Carassius gibelio cerebellum. Neurophysiology. 2009;41(4):231-7.
CrossRef
- Lukyanetz IA, Kostyk PG, Lukyanetz EA. Calcium signaling in Carassius cerebellar neurons: Role of the mitochondria. Neurophysiology. 2009;41(6):375-9.
CrossRef
- Kravenska EV, Chopovska VV, Yavorskaya EN, Lukyanetz EA. The role of mitochondria in the development of Alzheimer's disease. Tavrichesky Med-Biol Bull. 2012;15(3/2):147-9.
- Kravenska EV, Ganzha VV, Yavorskaya EN, Lukyanetz EA. Effect of cyclosporin a on the viability of hippocampal cells cultured under conditions of modeling of Alzheimer's disease. Neurophysiology. 2016;48(4):246-51.
CrossRef
- Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol. 2018;14:450-64.
CrossRef
PubMed PubMedCentral
- Meier T, Buyse G. Idebenone: an emerging therapy for Friedreich ataxia. J Neurol. 2009;256 Suppl 1:25-30.
CrossRef
PubMed
- Witte ME, Geurts JJG, de Vries HE, van der Valk P, van Horssen J. Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion. 2010;2010/06/01(5):411-8.
CrossRef
PubMed
- Phillips NR, Simpkins JW, Roby RK. Mitochondrial DNA deletions in Alzheimer's brains: a review. Alzheimers Dement. 2014;2013/07/11(3):393-400.
CrossRef
PubMed PubMedCentral
- Zhu X, Perry G, Smith MA, Wang X. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Alzheimers Dis. 2013;33 Suppl 1 (0 1):S253-S62.
CrossRef
PubMed PubMedCentral
- Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem. 1994;63(6):2179-84.
CrossRef
PubMed
- Morris GP, Clark IA, Vissel B. Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta Neuropathol Commun. 2014;2:135.
CrossRef
PubMed PubMedCentral
- Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM. Is Alzheimer's disease a systemic disease? Biochim Biophys Acta. 2014;2014/04/18(9):1340-9.
CrossRef
PubMed PubMedCentral
- Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci. 2006;26(35):9057-68.
CrossRef
PubMed PubMedCentral
- Mitophagy: Department of Anatomy, Chungnam National University School of Medicine, Daejeon, Republic of Korea; 2013. Available from: http://visnu528.blogspot. com/2013/04/mitophagy.html.
- Ge P, Dawson VL, Dawson TM. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease. Mol Neurodegener. 2020;15(1):20.
CrossRef
PubMed PubMedCentral
- Jin SM, Youle RJ. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci. 2012;125(Pt 4):795-9.
CrossRef
PubMed PubMedCentral
- Cai Q, Jeong YY. Mitophagy in Alzheimer's disease and other age-related neurodegenerative diseases. Cells. 2020;9(1):150.
CrossRef
PubMed PubMedCentral
- Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nat Neurosci. 2019;22(3):401-12.
CrossRef
PubMed PubMedCentral
- Chakravorty A, Jetto CT, Manjithaya R. Dysfunctional mitochondria and mitophagy as drivers of Alzheimer's disease pathogenesis. Front Aging Neurosci. 2019; 11(311).
CrossRef
PubMed PubMedCentral
- Scheibye-Knudsen M, Fang EF, Croteau DL, Wilson DM, 3rd, Bohr VA. Protecting the mitochondrial powerhouse. Trends Cell Biol. 2015;25(3):158-70.
CrossRef
PubMed PubMedCentral
- Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nat Neurosci. 2019;22(3):401-12.
CrossRef
PubMed PubMedCentral
- Sorrentino V, Romani M, Mouchiroud L, Beck JS, Zhang H, D'Amico D, et al. Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity. Nature. 2017;552(7684):187-93.
CrossRef
PubMed PubMedCentral
- Lautrup S, Lou G, Aman Y, Nilsen H, Tao J, Fang EF. Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease. Neurochem Int. 2019;129:104469.
CrossRef
PubMed
|